Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorKuwana, Masataka
dc.contributor.authorGil Vila, Albert
dc.contributor.authorSelva O'Callaghan, Albert
dc.date.accessioned2022-04-25T14:50:54Z
dc.date.available2022-04-25T14:50:54Z
dc.date.issued2021-01-01
dc.identifier.citationKuwana M, Gil-Vila A, Selva-O’Callaghan A. Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis. 2021 Jan 1;13:1–17.
dc.identifier.issn1759-7218
dc.identifier.urihttps://hdl.handle.net/11351/7405
dc.descriptionAutoanticossos; Trastorns reumàtics autoimmunes; Malaltia pulmonar intersticial
dc.description.sponsorshipThe authors received no financial support for the research, authorship, and/or publication of this article.
dc.language.isoeng
dc.publisherSAGE Publications
dc.relation.ispartofseriesTherapeutic Advances in Musculoskeletal Disease;13
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectPulmons - Malalties - Complicacions
dc.subjectMalalties autoimmunitàries
dc.subjectAutoanticossos
dc.subject.meshLung Diseases, Interstitial
dc.subject.mesh/complications
dc.subject.meshAutoimmune Diseases
dc.subject.meshAutoantibodies
dc.titleRole of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1177/1759720X211032457
dc.subject.decsenfermedades pulmonares intersticiales
dc.subject.decs/complicaciones
dc.subject.decsenfermedades autoinmunes
dc.subject.decsautoanticuerpos
dc.relation.publishversionhttps://doi.org/10.1177/1759720X211032457
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Kuwana M] Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine; Scleroderma/Myositis Center of Excellence (SMCE) Nippon Medical School Hospital, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, Japan. [Gil-Vila A, Selva-O'Callaghan A] Unitat de Malalties Autoimmunes Sistèmiques, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid34377160
dc.identifier.wos000688106300001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple